Repurposing some older drugs that cross the blood–brain barrier and have potential anticancer activity to provide new treatment options for glioblastoma
D Rundle‐Thiele, R Head, L Cosgrove… - British journal of …, 2016 - Wiley Online Library
Glioblastoma is a brain neoplasm with limited 5‐year survival rates. Developments of new
treatment regimens that improve patient survival in patients with glioblastoma are needed. It …
treatment regimens that improve patient survival in patients with glioblastoma are needed. It …
[HTML][HTML] Repurposing some older drugs that cross the blood–brain barrier and have potential anticancer activity to provide new treatment options for glioblastoma
D Rundle‐Thiele, R Head, L Cosgrove… - British Journal of …, 2016 - ncbi.nlm.nih.gov
Glioblastoma is a brain neoplasm with limited 5‐year survival rates. Developments of new
treatment regimens that improve patient survival in patients with glioblastoma are needed. It …
treatment regimens that improve patient survival in patients with glioblastoma are needed. It …
Repurposing some older drugs that cross the blood-brain barrier and have potential anticancer activity to provide new treatment options for glioblastoma.
D Rundle‐Thiele, R Head… - British Journal of …, 2016 - search.ebscohost.com
Glioblastoma is a brain neoplasm with limited 5-year survival rates. Developments of new
treatment regimens that improve patient survival in patients with glioblastoma are needed. It …
treatment regimens that improve patient survival in patients with glioblastoma are needed. It …
Repurposing some older drugs that cross the blood–brain barrier and have potential anticancer activity to provide new treatment options for glioblastoma
D Rundle‐Thiele, R Head, L Cosgrove… - British Journal of Clinical …, 2016 - infona.pl
Glioblastoma is a brain neoplasm with limited 5‐year survival rates. Developments of new
treatment regimens that improve patient survival in patients with glioblastoma are needed. It …
treatment regimens that improve patient survival in patients with glioblastoma are needed. It …
[引用][C] Repurposing some older drugs that cross the blood-brain barrier and have potential anticancer activity to provide new treatment options for glioblastoma
D Rundle-Thiele, R Head… - British Journal of …, 2016 - espace.library.uq.edu.au
Glioblastoma is a brain neoplasm with limited 5-year survival rates. Developments of new
treatment regimens that improve patient survival in patients with glioblastoma are needed. It …
treatment regimens that improve patient survival in patients with glioblastoma are needed. It …
Repurposing some older drugs that cross the blood-brain barrier and have potential anticancer activity to provide new treatment options for glioblastoma
D Rundle-Thiele, R Head… - British journal of …, 2016 - pubmed.ncbi.nlm.nih.gov
Glioblastoma is a brain neoplasm with limited 5-year survival rates. Developments of new
treatment regimens that improve patient survival in patients with glioblastoma are needed. It …
treatment regimens that improve patient survival in patients with glioblastoma are needed. It …
Repurposing some older drugs that cross the blood-brain barrier and have potential anticancer activity to provide new treatment options for glioblastoma.
D Rundle-Thiele, R Head, L Cosgrove… - British Journal of …, 2015 - europepmc.org
Glioblastoma is a brain neoplasm with limited 5‐year survival rates. Developments of new
treatment regimens that improve patient survival in patients with glioblastoma are needed. It …
treatment regimens that improve patient survival in patients with glioblastoma are needed. It …
Repurposing some older drugs that cross the blood-brain barrier and have potential anticancer activity to provide new treatment options for glioblastoma.
D Rundle-Thiele, R Head, L Cosgrove… - British Journal of …, 2015 - europepmc.org
Glioblastoma is a brain neoplasm with limited 5‐year survival rates. Developments of new
treatment regimens that improve patient survival in patients with glioblastoma are needed. It …
treatment regimens that improve patient survival in patients with glioblastoma are needed. It …